Keywords: novartis, sebo, gmbh, sign, hyperphosphatemia, drug, accord

Novartis and SeBo GmbH sign hyperphosphatemia drug accord

Article | 22 August 2005

Print This

Swiss drug major Novartis has signed an agreement with SeBo GmbH of Germany to acquire the global rights for a ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in